Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL7P5 is one of multiple processed pseudogenes for the ribosomal protein L7 (RPL7) gene, found dispersed throughout the human genome. Unlike the functional RPL7 gene, which codes for a constituent protein of the 60S ribosomal subunit, processed pseudogenes such as RPL7P5 do not produce a functional protein and typically lack regulatory elements and coding potential. RPL7P5 is not a receptor, enzyme, transporter, or conventional drug target[1][6][8]. There is no evidence linking RPL7P5 itself to specific biological function, disease mechanism, or drug interactions in the literature. Reports referencing RPL7 pseudogenes commonly note their existence as genomic relics or markers of gene duplication events, not as functional molecules[3][4][8].\n\nExplanation and clarification:\n- The functional protein, Ribosomal protein L7 (RPL7), is well-characterized and involved in ribosome assembly, but RPL7P5 is a pseudogene: it is DNA with similarity to RPL7 but does not produce a functional ribosomal protein[1][6][8].\n- Pseudogenes are not therapeutic targets—they do not encode active proteins or participate directly in molecular pathways as drugs or biologics targets[8].\n- There is no evidence in research databases or product catalogs that RPL7P5 serves any biomarker, therapeutic, or pharmacological role[3][6].\n\nConclusion:\nRPL7P5 is a pseudogene, not a functional protein or valid drug/receptor target. The only information available concerns its genomic status as a processed pseudogene of RPL7; it plays no known active role in cell biology or therapeutics[1][6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L7 pseudogene 5 (RPL7P5).